MedTrace is dedicated to becoming a global leader in perfusion imaging. Our products are designed to help patients be diagnosed quickly and accurately.
Our goal is to innovate PET diagnostic imaging by transforming blood flow quantification. We will do this by making 15O-water PET practically available in clinical settings.
Based in Denmark, Sweden, and the US, we are a team of diverse ages, cultures, and professional backgrounds.
Our company is collaborating with university hospitals in Europe, Japan, and the USA to develop and test our products. This is part of preparing our solution for regulatory approval in various regions of the world.
